3 EHR Vendors Meet Meaningful Use 2014 Standard, Creates Challenge for EPs Wishing to Achieve Stage 2

On September 4 2012, CMS published a final rule listing Stage 2 criteria that eligible professionals (EPs), hospitals, and critical access hospitals (CAHs) have to meet to continue to participation in Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs.

By June 13, 2013 only three vendors are ready for inpatient, and three for ambulatory on  the CMS website that shows which EHR vendors have their product certified for Meaningful Use under the 2014 Standard.

This creates an issue for all Eligible Providers (EPs) who achieved meaningful use Stage 1.  Unless their EHR vendor meets the Stage 2 requirements, those EPs no longer qualify for Meaningful Use stimulus dollars.

These developments come in the same year that all HIPAA Covered Entities should be moving toward ICD-10.

The 2014 Edition Standards and Certification Criteria final rule:

  • Introduces new privacy, security, interoperability, safety, portability, quality measures, and transitions of care standards.
  • Redefines the meaning of Certified EHR Technology while aiming to permit greater innovation and reduced regulatory burden;
  • Adopts certification criteria for transitions of care that will ensure EHR technology supports standards-based electronic health information exchange
  • Requires test reports used for EHR technology certification be made publicly available and that EHR technology developers follow certain price transparency practices related to the types of costs (i.e., one-time, ongoing, or both) associated with EHR technology implementation for meaningful use; and
  • Makes available for the first time, “gap certification” for certain certification criteria, which will enable more efficient EHR technology certification.
Related Posts

Michael Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. He leads a team that provides Cybersecurity best practices for healthcare clients, ICD-10 Consulting, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, Insurance Fraud, payor-provider disputes, and consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, stutdies at Harvard Law School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims).

Leave a Reply